Skip to main content

Table 5 Comparison with extrapolations from LSS12a

From: Low dose radiation and cancer in A-bomb survivors: latency and non-linear dose-response in the 1950–90 mortality cohort

Site gen LSS12 ERR1 b 2-p ERR1,φ c φm d trans ERR1,φ e φm f
Stomach M/F 0.0024 (0.001, 0.004) 0.46 (0.11, 0.94) 11.89 0.00 (-0.06, 0.16) 11.85
  M 0.001 (-0.0005, 0.0028) 2.68 (-0.15, 32.45) 6.14 0.00 (-0.21, 0.17) 21.77
  F 0.0047 (0.0022, 0.0077) 0.80 (0.15, 1.77) 13.67 0.43 (0.00, 0.96) 13.68
Liver M/F 0.0037 (0.0013, 0.0065) 1.43 (0.48, 2.95) 36.90 0.95 (0.28, 1.99) 36.90
  M 0.0048 (0.0017, 0.0088) 1.72 (0.40, 4.25) 36.97 1.30 (0.28, 3.10) 36.97
  F 0.0019 (-0.0011, 0.0062) 1.24 (0.06, 3.60) 36.90 1.09 (0.15, 2.78) 38.55
Lung M/F 0.0053 (0.0028, 0.0084) 0.88 (0.12, 3.36) 13.60 0.80 (0.19, 1.99) 13.60
  M 0.0034 (0.0006, 0.0069) 0.78 (-0.11, 4.91) 13.55 0.74 (0.05, 2.40) 13.55
  F 0.0089 (0.0041, 0.0151) 1.35 (0.07, 4.83) 21.91 1.04 (0.09, 3.28) 21.91
Colon M/F 0.0065 (0.0023, 0.0121) 0.05 (-0.53, 1.15) 20.28 0.07 (-0.49, 1.71) 43.98
  M 0.0048 (-0.0002, 0.0127) 0.30 (-0.59, 3.16) 28.63 0.40 (-0.50, 2.72) 28.63
  F 0.0081 (0.0022, 0.0077) 0.47 (-0.55, 2.96) 41.62 0.29 (-0.78, 2.26) 41.62
Uterus F 0.0024 (-0.0006, 0.0067) 0.47 (-0.32, 2.12) 26.91 0.000 (-0.23, 1.06) 26.91
Site gen LSS12 ERR 0.025 b 2-p ERR 0.025,φ c φ m d trans ERR 0.025,φ d φ m f
Stomach M/F 0.00006 (0.000025, 0.0001) 0.39 (0.08, 0.86) 11.89 0.08 (-0.11, 0.23) 11.85
  M 0.001 (-0.0005, 0.0028) 2.43 (-0.23, 31.08) 6.14 0.16 (-0.16, 0.47) 21.77
  F 0.0047 (0.0022, 0.0077) 0.71 (0.05, 1.62) 13.67 0.30 (0.01, 0.76) 13.68
Liver M/F 0.000093 (0.000033, 0.00016) 1.10 (0.26, 2.37) 36.90 0.77 (0.18, 1.67) 36.90
  M 0.00012 (0.000043, 0.00022) 1.30 (0.12, 3.50) 36.97 1.25 (0.25, 3.00) 36.97
  F 0.000048 (-0.000028, 0.00016) 1.03 (0.04, 2.94) 36.90 0.43 (0.01, 1.46) 38.55
Lung M/F 0.00013 (0.00007, 0.00021) 0.86 (0.14, 3.34) 13.60 0.79 (0.20, 2.01) 13.60
  M 0.000085 (0.000015, 0.00014) 0.96 (-0.05, 5.39) 13.55 0.92 (0.12, 2.92) 13.55
  F 0.00022 (0.0001, 0.00038) 1.12 (0.08, 4.15) 21.91 0.91 (0.10, 2.87) 21.91
Colon M/F 0.00017 (0.00006, 0.0003) 0.25 (-0.44, 1.46) 20.28 0.58 (-0.25, 1.85) 43.98
  M 0.00012 (-0.000005, 0.00032) 0.65 (-0.45, 4.34) 28.63 0.72 (-0.30, 3.72) 28.63
  F 0.0002 (0.000055, 0.00019) 0.94 (-0.21, 3.17) 41.62 0.85 (-0.15, 2.56) 41.62
Uterus F 0.00006 (-0.000015, 0.00017) 0.66 (-0.10, 2.44) 26.91 0.25 (-0.09, 1.13) 26.91
  1. aLife Span Study Report 12 [4]
  2. bfrom LSS12 Tables AII, AIII and AIV, scaled by the linear assumption ERR1 = ERR per 10 mSv = 0.01(ERR per Sv) and ERR0.025 = 0.00025(ERR per Sv)
  3. cTwo-phase model fitted to 0 – 20 mSv subcohort at optimal latency (see also Table 3 for M/F results)
  4. dOptimal latency for Two-phase model on 0 – 20 mSv subcohort
  5. eTransient model at fitted to 0 – 20 mSv subcohort at optimal latency (see also Table 2 for M/F results)
  6. fOptimal latency for Transient model on 0 – 20 mSv subcohort